![Ontario woman with rare disease forced to pay hundreds of thousands to cover 'miracle drug' | Globalnews.ca Ontario woman with rare disease forced to pay hundreds of thousands to cover 'miracle drug' | Globalnews.ca](https://i2.wp.com/media.globalnews.ca/videostatic/532/203/ONLINE_DRUG_DENIED_PT_ONE_hayes_april_3_848x480_1471588931922.jpg?w=1040&quality=70&strip=all)
Ontario woman with rare disease forced to pay hundreds of thousands to cover 'miracle drug' | Globalnews.ca
Pharmac agrees to fund drug for those with spinal muscular atrophy after years of lobbying | RNZ News
![Ministarstvo zdravstva potvrdilo – sva djeca oboljela od spinalne mišićne atrofije dobit će lijek Spinrazu | Teklić Ministarstvo zdravstva potvrdilo – sva djeca oboljela od spinalne mišićne atrofije dobit će lijek Spinrazu | Teklić](https://www.teklic.hr/slike/2018/07/spinraza.jpg)
Ministarstvo zdravstva potvrdilo – sva djeca oboljela od spinalne mišićne atrofije dobit će lijek Spinrazu | Teklić
![Medicine for rare-disease to benefit more patients after being included in China's medicare reimbursement list-Xinhua Medicine for rare-disease to benefit more patients after being included in China's medicare reimbursement list-Xinhua](http://english.news.cn/20220102/30241360753145949b35a7459d672504/2022010230241360753145949b35a7459d672504_cc506357-824d-4661-9a10-02c5a6a5309b.jpg)
Medicine for rare-disease to benefit more patients after being included in China's medicare reimbursement list-Xinhua
![Life-changing drug for babies with devastating genetic condition rejected by NICE | Muscular Dystrophy UK Life-changing drug for babies with devastating genetic condition rejected by NICE | Muscular Dystrophy UK](https://www.musculardystrophyuk.org/static/s3fs-public/styles/large_hero_image_968x545/public/Spinraza.png?VersionId=O1xBqjWUdz2mS7Kha4Sbkr8FY8xios6G&itok=WEirFWDB)
Life-changing drug for babies with devastating genetic condition rejected by NICE | Muscular Dystrophy UK
![Another Zolgensma delay is bad for Novartis in SMA but good for Biogen's Spinraza: analyst | Fierce Pharma Another Zolgensma delay is bad for Novartis in SMA but good for Biogen's Spinraza: analyst | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1585835687/Vialandbox_1558464320138-HR.jpg/Vialandbox_1558464320138-HR.jpg?VersionId=fozo8KWxTJ8t0hKqSl.e40NlC6w8Q50Q)